c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion
Kenjiro Sawada(Gynecologic Oncology Group), Ernst Lengyel(University of Illinois Chicago), Amy R. Becker(Gynecologic Oncology Group), Muge Turkyilmaz, Nariyoshi Shinomiya(National Institute of Infectious Diseases), A. Reza Radjabi(Gynecologic Oncology Group), Emily O. Kistner, Hilary A. Kenny(Gynecologic Oncology Group), George F. Vande Woude(Van Andel Institute), Ravi Salgia(City Of Hope National Medical Center), S. Diane Yamada(University of Chicago), Maria Tretiakova(University of Washington)
Cited by 260
Related Papers
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Ovarian Cancer Development and Metastasis
|American Journal Of Pathology|2010|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k